(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Hostess Brands, Rumble, and Vroom.

The three biggest losers today are Archer, Uxin Limited, and Taoping.

Winners today

1. Hostess Brands (TWNKW) – 41.59%

Hostess Brands, Inc., a packaged food company, develops, manufactures, markets, sells, and distributes fresh sweet baked goods in the United States. It primarily offer a range of snack cakes, donuts, sweet rolls, breakfast pastries, snack pies, and related products. The company operates in two segments, Sweet Baked Goods and In-Store Bakery. The Sweet Baked Goods segment offers fresh and frozen sweet baked goods and bread products under the Hostess, Dolly Madison, Cloverhill, and Big Texas brands, as well as store branded products. The In-Store Bakery segment primarily provides Superior on Main branded eclairs, madeleines, brownies, and iced cookies in the bakery section of grocery and club stores. The company was formerly known as Gores Holdings, Inc. and changed its name to Hostess Brands, Inc. in November 2016. Hostess Brands, Inc. was founded in 1919 and is based in Lenexa, Kansas.

NASDAQ ended the session with Hostess Brands rising 41.59% to $3.20 on Monday while NASDAQ jumped 0.32% to $15,360.29.

PE Ratio

Hostess Brands has a trailing twelve months price to earnings ratio of 5.15. Meaning, the purchaser of the share is investing $5.15 for every dollar of annual earnings.

Moving Average

Hostess Brands’s worth is under its 50-day moving average of $3.36 and way higher than its 200-day moving average of $2.53.

Volume

Today’s last reported volume for Hostess Brands is 29718 which is 70.4% below its average volume of 100427.

More news about Hostess Brands.

2. Rumble (RUM) – 31.91%

Rumble Inc. operates video sharing platforms in the United States, Canada, and internationally. The company operates rumble.com, a platform where users can subscribe to channels to stay in touch with creators, and access video on-demand (VOD) and live content streamed by creators. It also operates locals.com, a subscription platform for creators and subscribers to engage through VOD, podcasts, live chat, polls, and community discussions; and Rumble Advertising Center (RAC), an online advertising management exchange. The company was founded in 2013 and is headquartered in Longboat Key, Florida.

NASDAQ ended the session with Rumble rising 31.91% to $4.74 on Monday, after two successive sessions in a row of gains. NASDAQ jumped 0.32% to $15,360.29, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Rumble has a trailing twelve months EPS of $-0.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.68%.

Volatility

Rumble’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.62%, a negative 1.91%, and a positive 3.70%.

Rumble’s highest amplitude of average volatility was 7.93% (last week), 4.80% (last month), and 3.70% (last quarter).

Sales Growth

Rumble’s sales growth is 41% for the present quarter and 27.6% for the next.

More news about Rumble.

3. Vroom (VRM) – 13.95%

Vroom, Inc. operates an e-commerce platform for buying, selling, and trading of new and used cars in the United States. It also offers financing solutions. The company was formerly known as Auto America, Inc. and changed its name to Vroom, Inc. in July 2015. The company was founded in 2012 and is headquartered in New York, New York.

NASDAQ ended the session with Vroom jumping 13.95% to $0.50 on Monday, following the last session’s upward trend. NASDAQ jumped 0.32% to $15,360.29, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Vroom has a trailing twelve months EPS of $-1.43.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.71%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 30.9%, now sitting on 866.63M for the twelve trailing months.

Sales Growth

Vroom’s sales growth is 19.6% for the current quarter and negative 2.1% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Vroom’s EBITDA is -17.4.

More news about Vroom.

4. FibroGen (FGEN) – 13.46%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen jumping 13.46% to $0.87 on Monday while NASDAQ rose 0.32% to $15,360.29.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-3.06.

Volume

Today’s last reported volume for FibroGen is 984095 which is 43.94% below its average volume of 1755720.

Yearly Top and Bottom Value

FibroGen’s stock is valued at $0.87 at 16:32 EST, way below its 52-week high of $25.69 and way above its 52-week low of $0.33.

Sales Growth

FibroGen’s sales growth is 5.3% for the present quarter and 16.4% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

FibroGen’s EBITDA is 1.67.

More news about FibroGen.

5. Beyond Air (XAIR) – 11.88%

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of lung infections, persistent pulmonary hypertension of the newborn, severe acute respiratory syndrome coronavirus 2, bronchiolitis, and nontuberculous mycobacteria.The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.

NASDAQ ended the session with Beyond Air jumping 11.88% to $1.46 on Monday, after four sequential sessions in a row of losses. NASDAQ jumped 0.32% to $15,360.29, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Beyond Air has a trailing twelve months EPS of $-2.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -145.82%.

More news about Beyond Air.

6. LendingTree (TREE) – 10.12%

LendingTree, Inc., through its subsidiary, LT Intermediate Company, LLC, operates online consumer platform in the United States. It operates through three segments: Home, Consumer, and Insurance. The Home segment offers purchase mortgage, refinance mortgage, reverse mortgage, and home equity loans; lines of credit; and real estate brokerage services. The Consumer segment provides credit cards; personal, small business, student, and auto loans; deposit accounts; and other credit products, such as credit repair and debt settlement services. The Insurance segment includes information, tools, and access to insurance quote products, including home and automobile, through which consumers are matched with insurance lead aggregators to obtain insurance offers. In addition, the company offers QuoteWizard.com, a marketplace for insurance comparison; ValuePenguin, a personal finance website that offers consumers objective analysis on various financial topics from insurance to credit cards; and Stash, a consumer investing and banking platform that offers a suite of personal investment accounts, traditional and Roth IRAs, custodial investment accounts, and banking services, including checking accounts and debit cards with a Stock-Back rewards program. The company was formerly known as Tree.com, Inc. and changed its name to LendingTree, Inc. in January 2015. LendingTree, Inc. was incorporated in 1996 and is based in Charlotte, North Carolina.

NASDAQ ended the session with LendingTree rising 10.12% to $30.46 on Monday, after two sequential sessions in a row of gains. NASDAQ rose 0.32% to $15,360.29, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, LendingTree has a trailing twelve months EPS of $-11.27.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -94.15%.

Volatility

LendingTree’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.91%, a negative 0.65%, and a positive 4.45%.

LendingTree’s highest amplitude of average volatility was 4.15% (last week), 4.48% (last month), and 4.45% (last quarter).

More news about LendingTree.

7. Redfin (RDFN) – 8.36%

Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; and originates and sells mortgages. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.

NASDAQ ended the session with Redfin jumping 8.36% to $8.61 on Monday while NASDAQ jumped 0.32% to $15,360.29.

Earnings Per Share

As for profitability, Redfin has a trailing twelve months EPS of $-1.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -209.25%.

More news about Redfin.

8. Vislink Technologies (VISL) – 6.94%

Vislink Technologies, Inc. designs, develops, and delivers wireless communications solutions in North and South America, Europe, Asia, and internationally. It develops, manufactures, and sells microwave communications equipment and video transmission products under the Nucomm, RF Central, and IMT brand names for broadcast, sports and entertainment, and government/surveillance markets. The company also offers satellite communication, cellular, and wireless camera systems and associated amplifier items, as well as microwave radio components under the Vislink brand to broadcasters, network owners and station groups, sports and live broadcasters, hosted service providers, and defense agencies and organizations, as well as metropolitan, regional, and national law enforcement agenciesIts products portfolio consists of HCAM, an on-camera wireless video transmitter; HDX-1100, an aircraft downlink transmitter; ViewBack, a dual channel diversity receiver-decoder; SatWare, an embedded computing and routing system; and AirPro-75, an IP satellite data terminal, as well as various types of receivers. The company was formerly known as xG Technology, Inc. and changed its name to Vislink Technologies, Inc. in February 2019. Vislink Technologies, Inc. was founded in 2002 and is headquartered in Sarasota, Florida.

NASDAQ ended the session with Vislink Technologies rising 6.94% to $3.39 on Monday while NASDAQ jumped 0.32% to $15,360.29.

Earnings Per Share

As for profitability, Vislink Technologies has a trailing twelve months EPS of $-5.18.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.29%.

Moving Average

Vislink Technologies’s value is under its 50-day moving average of $3.69 and way below its 200-day moving average of $4.70.

Yearly Top and Bottom Value

Vislink Technologies’s stock is valued at $3.39 at 16:32 EST, way below its 52-week high of $14.40 and way above its 52-week low of $2.31.

More news about Vislink Technologies.

9. Fastly (FSLY) – 6.53%

Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally. The edge cloud is a category of Infrastructure as a Service that enables developers to build, secure, and deliver digital experiences at the edge of the internet. It is a programmable platform designed for web and application delivery. The company offers Compute@Edge; network services to speed up and optimize the delivery of web and application traffic; device detection and geolocation; content delivery network, such as dynamic site acceleration, origin shield, instant purge, surrogate keys, programmatic control, content compression, reliability, and modern protocols and performance services; and streaming solutions and services, including live streaming and media shield. It also provides edge security solutions, such as DDoS protection, next-gen WAF, bot protection, API and ATO protection, advanced rate limiting, and compliance services; transport layer security (TLS) and platform TLS; and origin connect. In addition, the company offers edge applications, such as load balancers and image optimizers; video on demand; and edge delivery services. It serves customers operating in digital publishing, media and entertainment, technology, online retail and education, SaaS, travel and hospitality, and financial services industries. The company was formerly known as SkyCache, Inc. and changed its name to Fastly, Inc. in May 2012. Fastly, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.

NYSE ended the session with Fastly jumping 6.53% to $19.99 on Monday while NYSE jumped 0.31% to $16,780.78.

Earnings Per Share

As for profitability, Fastly has a trailing twelve months EPS of $-1.24.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.16%.

Volatility

Fastly’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.14%, a negative 0.23%, and a positive 3.59%.

Fastly’s highest amplitude of average volatility was 1.16% (last week), 2.81% (last month), and 3.59% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 487.53M for the twelve trailing months.

Moving Average

Fastly’s worth is way above its 50-day moving average of $17.64 and way higher than its 200-day moving average of $17.26.

More news about Fastly.

10. So-Young International (SY) – 6.32%

So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment in the People's Republic of China and internationally. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment. As of December 31, 2020, it had approximately 6,900 medical aesthetic service providers and 4,200 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment in the People's Republic of China and internationally. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment. As of December 31, 2020, it had approximately 6,900 medical aesthetic service providers and 4,200 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.

NASDAQ ended the session with So-Young International jumping 6.32% to $1.01 on Monday, following the last session’s upward trend. NASDAQ jumped 0.32% to $15,360.29, after two successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, So-Young International has a trailing twelve months EPS of $0.05.

PE Ratio

So-Young International has a trailing twelve months price to earnings ratio of 20.2. Meaning, the purchaser of the share is investing $20.2 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.51%.

Moving Average

So-Young International’s worth is way under its 50-day moving average of $1.17 and way under its 200-day moving average of $1.59.

Earnings Before Interest, Taxes, Depreciation, and Amortization

So-Young International’s EBITDA is 49.34.

More news about So-Young International.

Losers Today

1. Archer (ADM) – -23.35%

Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. The company operates in three segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. It originates, merchandises, stores, and transports agricultural raw materials, such as oilseeds and soft seeds. The company also engages in the agricultural commodity and feed product import, export, and distribution; and structured trade finance activities. In addition, it offers vegetable oils and protein meals; ingredients for the food, feed, energy, and industrial customers; crude vegetable oils, salad oils, margarine, shortening, and other food products; and partially refined oils to produce biodiesel and glycols for use in chemicals, paints, and other industrial products. Further, the company provides peanuts, peanut-derived ingredients, and cotton cellulose pulp; sweeteners, corn and wheat starches, syrup, glucose, wheat flour, and dextrose; alcohol and other food and animal feed ingredients; ethyl alcohol and ethanol; corn gluten feed and meal; distillers' grains; and citric acids. Additionally, the company provides natural flavors, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, enzymes, and botanical extracts; and other specialty food and feed ingredients; edible beans; formula feeds, and animal health and nutrition products; and contract and private label pet treats and foods. It also offers futures commission merchant; commodity brokerage services; cash margins and securities pledged to commodity exchange clearinghouses; and cash pledged as security under certain insurance arrangements. The company was founded in 1902 and is headquartered in Chicago, Illinois.

NYSE ended the session with Archer dropping 23.35% to $52.27 on Monday, after four consecutive sessions in a row of losses. NYSE rose 0.31% to $16,780.78, after two sequential sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Archer has a trailing twelve months EPS of $7.19.

PE Ratio

Archer has a trailing twelve months price to earnings ratio of 7.27. Meaning, the purchaser of the share is investing $7.27 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.82%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Archer’s EBITDA is 33.75.

More news about Archer.

2. Uxin Limited (UXIN) – -13.5%

Uxin Limited, an investment holding company, operates a used car e-commerce platform in China. It provides selection of used cars, evaluation of car condition, various car-related value-added products and services, and supporting services to online used car transactions under the Uxin Used Car brand; and operates Uxin Auction, an application that helps business buyers to source vehicles through online auctions. The company also facilitates used car transaction services, and financing solutions offered by third-party financing partners to buyers for their used car purchases through websites, xin.com and youxinpai.com. Uxin Limited was founded in 2011 and is headquartered in Beijing, China.

NASDAQ ended the session with Uxin Limited falling 13.5% to $2.69 on Monday while NASDAQ jumped 0.32% to $15,360.29.

Earnings Per Share

As for profitability, Uxin Limited has a trailing twelve months EPS of $-36.46.

Moving Average

Uxin Limited’s value is way under its 50-day moving average of $7.99 and way below its 200-day moving average of $13.12.

More news about Uxin Limited.

3. Taoping (TAOP) – -12.21%

Taoping Inc. provides cloud-based platform, resource sharing, and big data solutions to the Chinese new media, education residential community management, and elevator Internet of Things (IoT) industries in the People's Republic of China. It operates through three segments: Cloud-Based Technology, Blockchain Technology, and Traditional Information Technology. The company offers cloud-based software as a service to automate the interactive workflows between advertising agencies and their customers, including establishing new advertising projects, submitting advertisement proposals, revising and approving advertising proposals, processing payment online, remotely uploading advertisement content, and tracking and analyzing performance data. It also provides project-based technology products and services for the public sector; and software and hardware with integrated solutions, including information technology infrastructure, Internet-enabled display technologies, and IoT platforms to customers in government, education, residential community management, media, transportation, healthcare, and other private sectors, as well as related maintenance and support services. In addition, the company offers cloud-application-terminal and IoT technology based digital advertising distribution network and media resource sharing platform in the out-of-home advertising markets. Further, it operates Taoping Net, an advertising-resources trading service platform, which connect screen owners, advertisers, and consumers; Taoping App, which enable customers to distribute and manage ads from mobile terminals; and cryptocurrency mining and blockchain related services. The company was formerly known as China Information Technology, Inc. and changed its name to Taoping Inc. in June 2018. Taoping Inc. was founded in 1993 and is headquartered in Causeway Bay, Hong Kong.

NASDAQ ended the session with Taoping dropping 12.21% to $0.83 on Monday while NASDAQ jumped 0.32% to $15,360.29.

Earnings Per Share

As for profitability, Taoping has a trailing twelve months EPS of $-0.35.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.28%.

Yearly Top and Bottom Value

Taoping’s stock is valued at $0.83 at 16:32 EST, way below its 52-week high of $10.20 and above its 52-week low of $0.80.

Moving Average

Taoping’s worth is way below its 50-day moving average of $1.42 and way under its 200-day moving average of $3.82.

Volume

Today’s last reported volume for Taoping is 103535 which is 63.46% below its average volume of 283424.

More news about Taoping.

4. Gilead Sciences (GILD) – -11.22%

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc., and Tentarix Biotherapeutics Inc., as well as a partnership with Assembly Biosciences, Inc. to develop next-generation therapeutics for serious viral diseases. The company was incorporated in 1987 and is headquartered in Foster City, California.

NASDAQ ended the session with Gilead Sciences falling 11.22% to $77.50 on Monday while NASDAQ jumped 0.32% to $15,360.29.

Earnings Per Share

As for profitability, Gilead Sciences has a trailing twelve months EPS of $4.67.

PE Ratio

Gilead Sciences has a trailing twelve months price to earnings ratio of 16.6. Meaning, the purchaser of the share is investing $16.6 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.92%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.1%, now sitting on 27.39B for the twelve trailing months.

More news about Gilead Sciences.

5. Veru (VERU) – -10.84%

Veru Inc., an oncology and urology biopharmaceutical company, engages in developing novel medicines for prostate cancer treatment and prostate cancer supportive care. The company's oncology drug candidates include VERU-111, an oral alpha and beta tubulin inhibitor, which is in a development Phase 1b/2 for the treatment of metastatic castration resistant prostate cancer; Zuclomiphene citrate, which is in a Phase 2 clinical trial for the treatment of hot flashes in men undergoing androgen deprivation therapies; and VERU-100, a GnRH antagonist that is in planned Phase 2 clinical trial for the palliative treatment of advanced prostate cancer. Its urology specialty drug candidates are TADFIN, a tadalafil and finasteride combination of tablets and capsules for the treatment of men with lower urinary tract symptoms; and Tamsulosin XR capsules, which are tamsulosin capsules for treating benign prostatic hyperplasia. The company's commercial products include the FC2 Female/Internal condoms for the prevention of pregnancy and sexually transmitted infections; and PREBOOST 4% benzocaine wipes for the prevention of premature ejaculation. Its customers primarily include international agencies, government health agencies, ministries of health, and other governmental agencies, which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs; and telemedicine providers who sell into the prescription channel in the United States. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. is headquartered in Miami, Florida.

NASDAQ ended the session with Veru sliding 10.84% to $0.37 on Monday, after two successive sessions in a row of losses. NASDAQ jumped 0.32% to $15,360.29, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Veru has a trailing twelve months EPS of $-1.1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -188.78%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Veru’s EBITDA is -6.42.

More news about Veru.

6. Protara Therapeutics (TARA) – -10.75%

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

NASDAQ ended the session with Protara Therapeutics dropping 10.75% to $1.91 on Monday while NASDAQ rose 0.32% to $15,360.29.

Earnings Per Share

As for profitability, Protara Therapeutics has a trailing twelve months EPS of $-6.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -64%.

More news about Protara Therapeutics .

7. Summit Wireless Technologies (WISA) – -10.69%

Summit Wireless Technologies, Inc. develops wireless audio integrated circuits for home entertainment and professional audio markets in the United States, Europe, and the Asia Pacific. It offers TX modules for integration into televisions, audio-visual receivers, media hubs, and USB or HDMI dongles; and speaker systems. The company sells its products directly to original equipment manufacturers. The company was formerly known as Summit Semiconductor, Inc. and changed its name to Summit Wireless Technologies, Inc. in September 2018. Summit Semiconductor, Inc. was founded in 2010 and is headquartered in San Jose, California.

NASDAQ ended the session with Summit Wireless Technologies falling 10.69% to $0.10 on Monday, after five sequential sessions in a row of losses. NASDAQ rose 0.32% to $15,360.29, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Summit Wireless Technologies has a trailing twelve months EPS of $-1.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -508.19%.

Yearly Top and Bottom Value

Summit Wireless Technologies’s stock is valued at $0.10 at 16:32 EST, way below its 52-week high of $23.00 and way higher than its 52-week low of $0.09.

Moving Average

Summit Wireless Technologies’s worth is way under its 50-day moving average of $0.13 and way under its 200-day moving average of $0.79.

Revenue Growth

Year-on-year quarterly revenue growth declined by 17.9%, now sitting on 2.58M for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 98.5% and 64.2%, respectively.

More news about Summit Wireless Technologies.

8. Afya (AFYA) – -8.85%

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

NASDAQ ended the session with Afya sliding 8.85% to $20.39 on Monday, after four sequential sessions in a row of gains. NASDAQ rose 0.32% to $15,360.29, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Afya has a trailing twelve months EPS of $0.8.

PE Ratio

Afya has a trailing twelve months price to earnings ratio of 25.49. Meaning, the purchaser of the share is investing $25.49 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.15%.

More news about Afya.

9. Exicure (XCUR) – -6.67%

Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes AST-008 that is in a Phase 1b/2 clinical trials in patients with advanced solid tumors. The company is also developing XCUR-FXN, an SNA–based therapeutic candidate that is in preclinical trials for the treatment of Friedreich's ataxia; and XCUR17, an SNA that targets the messenger RNA (mRNA) encoding interleukin 17 receptor alpha. It has a collaboration, option, and license agreement with Allergan Pharmaceuticals International Limited to develop SNA-based treatments for hair loss disorders; and license and development agreement with DERMELIX, LLC to research, develop, and commercialize its technology for the treatment of netherton syndrome. The company was founded in 2011 and is based in Chicago, Illinois.

NASDAQ ended the session with Exicure sliding 6.67% to $0.56 on Monday while NASDAQ rose 0.32% to $15,360.29.

Earnings Per Share

As for profitability, Exicure has a trailing twelve months EPS of $1.77.

PE Ratio

Exicure has a trailing twelve months price to earnings ratio of 0.32. Meaning, the purchaser of the share is investing $0.32 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 56.4%.

Moving Average

Exicure’s worth is under its 50-day moving average of $0.57 and way under its 200-day moving average of $0.84.

More news about Exicure.

10. Westwater Resources (WWR) – -5.51%

Westwater Resources, Inc. operates as a diversified energy materials development company. It primarily explores for lithium, graphite, uranium, and Vanadium deposits. The company's principal project is the Coosa graphite project covering an area of approximately 41,965 acres situated in east-central Alabama. It also holds interest in lithium projects, which include Columbus Basin project covers an area of approximately 14,200 acres comprise of 2 blocks of unpatented placer claims located in western Nevada; and the Sal Rica Project covers an area of approximately 13,260 acres situated in the northwestern Utah. It addition, the company holds interests in various uranium projects, including 188,700 acres in the west-central part of the New Mexico; and Texas. The company was formerly known as Uranium Resources, Inc. and changed its name to Westwater Resources, Inc. in August 2017. Westwater Resources, Inc. was founded in 1977 and is based in Centennial, Colorado.

NASDAQ ended the session with Westwater Resources dropping 5.51% to $0.48 on Monday, after five consecutive sessions in a row of losses. NASDAQ jumped 0.32% to $15,360.29, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Westwater Resources has a trailing twelve months EPS of $-0.23.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.03%.

Yearly Top and Bottom Value

Westwater Resources’s stock is valued at $0.48 at 16:32 EST, under its 52-week low of $0.48.

More news about Westwater Resources.

Stay up to date with our winners and losers daily report